AbbVie to expand immunology pipeline with Nimble Therapeutics acquisition

Pallavi Madhiraju- December 14, 2024 0

In a significant move to solidify its presence in immunology, AbbVie has announced the acquisition of Nimble Therapeutics, a company at the forefront of peptide-based ... Read More

Huge pharmaceutical deal: Platinum Equity gains control of Inventia Healthcare’s key division

Pallavi Madhiraju- August 30, 2024 0

In a significant move within the global pharmaceutical sector, Platinum Equity has secured a controlling stake in the Oral Solid Dosage (OSD) business of Inventia ... Read More

Nestlé Health Science to acquire VOWST assets from Seres Therapeutics

Pallavi Madhiraju- June 8, 2024 0

Seres Therapeutics, Inc. (Nasdaq: MCRB) has announced a significant development in its partnership with Nestlé Health Science—a non-binding memorandum of understanding whereby Nestlé Health Science ... Read More

Cycle Pharmaceuticals proposes $466m acquisition of Vanda Pharmaceuticals

Pallavi Madhiraju- June 8, 2024 0

In a significant development within the pharmaceutical industry, UK-based Cycle Pharmaceuticals has offered to acquire Nasdaq-listed Vanda Pharmaceuticals in an all-cash transaction valued at $466 ... Read More

Jazz Pharmaceuticals to acquire GW Pharmaceuticals in $7.2bn deal

pharmanewsdaily- February 3, 2021 0

In a significant move within the pharmaceutical industry, Irish biopharma company Jazz Pharmaceuticals has announced an agreement to acquire British-based GW Pharmaceuticals in a monumental ... Read More

Nordic Capital proposes $846m acquisition of Advanz Pharma

pharmanewsdaily- January 27, 2021 0

In a significant move within the pharmaceutical industry, Nordic Capital has made a formal offer to acquire Advanz Pharma, a UK-based specialty pharmaceutical company, for ... Read More

Takeda’s $62bn acquisition of Shire: A game-changing move for global pharma

pharmanewsdaily- January 20, 2019 0

In a landmark deal, Takeda Pharmaceutical Company has successfully completed its previously announced acquisition of Shire, an Irish biotech leader specializing in rare diseases, for ... Read More

Lilly to acquire Loxo Oncology in $8bn deal: A game-changer in precision cancer treatment

pharmanewsdaily- January 13, 2019 0

Eli Lilly and Company (Lilly), a global leader in pharmaceuticals, has made headlines with its announcement to acquire Loxo Oncology, a pioneering biopharmaceutical company based ... Read More

Novartis completes $2.1bn acquisition of Endocyte to boost cancer treatment capabilities

pallavi123- December 23, 2018 0

Swiss pharmaceutical giant Novartis has officially closed its $2.1 billion acquisition of US-based biopharma company Endocyte, solidifying its position as a leader in radiopharmaceuticals for ... Read More

Astellas Pharma acquires Potenza Therapeutics in $404.7m deal

pharmanewsdaily- December 16, 2018 0

Japanese pharmaceutical giant Astellas Pharma has announced the acquisition of US-based Potenza Therapeutics in a significant transaction valued at up to $404.7 million. This strategic ... Read More